Smith M R, Matthews N T, Jones K A, Kung H F
Biological Carcinogenesis and Development Program, Program Resources Inc., DynCorp, National Cancer Institute, Frederick Cancer Research and Development Center, MD 21702.
Pharmacol Ther. 1993;58(2):211-36. doi: 10.1016/0163-7258(93)90050-n.
Cancer, in many cases, results from multistep genetic mutation. Certain genes can have a predisposed susceptibility to mutations that lead to cancer because of chromosome location or their importance in the control of cell cycles. Mutations that deregulate the expression or activity of enzymes involved in the biochemical pathways of growth and differentiation or that suppress the expression of negative cell cycle control factors result in activation of oncogenesis. The study of oncogenes and tumor suppressor genes has greatly influenced our understanding of the molecular origins of cancer. We focus here on the normal biological action of proto-oncogenes compared with the transforming activities of oncogenes and tumor suppressor genes, and we discuss possible mechanisms of oncogenic transformation.
在许多情况下,癌症是由多步骤基因突变导致的。某些基因由于染色体位置或其在细胞周期控制中的重要性,对导致癌症的突变具有易感性。那些使参与生长和分化生化途径的酶的表达或活性失调,或者抑制细胞周期负调控因子表达的突变,会导致肿瘤发生的激活。对癌基因和肿瘤抑制基因的研究极大地影响了我们对癌症分子起源的理解。我们在此聚焦原癌基因的正常生物学作用,并将其与癌基因和肿瘤抑制基因的转化活性进行比较,同时探讨致癌转化的可能机制。